Fosamac


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 38.2%
Product Used For Unknown Indication 17.1%
Rheumatoid Arthritis 13.6%
Osteoporosis 6.5%
Hypertension 4.5%
Prophylaxis 3.5%
Back Pain 3.0%
Hyperlipidaemia 1.5%
Insomnia 1.5%
Osteoporosis Prophylaxis 1.5%
Reflux Oesophagitis 1.5%
Basedow's Disease 1.0%
Connective Tissue Disorder 1.0%
Idiopathic Pulmonary Fibrosis 1.0%
Interstitial Lung Disease 1.0%
Parkinson's Disease 1.0%
Promotion Of Peripheral Circulation 1.0%
Antibiotic Prophylaxis 0.5%
Antifungal Prophylaxis 0.5%
Bone Density Decreased 0.5%
Sepsis 20.0%
Hepatic Enzyme Increased 12.0%
Interstitial Lung Disease 8.0%
Pyrexia 8.0%
White Blood Cell Count Decreased 8.0%
Agranulocytosis 4.0%
Breast Cancer 4.0%
Calculus Urinary 4.0%
Hepatic Function Abnormal 4.0%
Hyperkalaemia 4.0%
Liver Disorder 4.0%
Neuroleptic Malignant Syndrome 4.0%
Rhabdomyolysis 4.0%
Skin Ulcer 4.0%
Stevens-johnson Syndrome 4.0%
Visual Acuity Reduced 4.0%
Concomitant
Rheumatoid Arthritis 29.9%
Prophylaxis 11.1%
Osteoporosis 10.4%
Product Used For Unknown Indication 9.0%
Hypertension 6.7%
Drug Use For Unknown Indication 4.3%
Pain 2.8%
Asthma 2.6%
Insomnia 2.3%
Lupus Nephritis 2.2%
Osteoporosis Prophylaxis 2.2%
Gastritis 2.1%
Constipation 2.1%
Idiopathic Pulmonary Fibrosis 2.1%
Behcet's Syndrome 1.9%
Hyperlipidaemia 1.8%
Idiopathic Thrombocytopenic Purpura 1.8%
Prophylaxis Against Gastrointestinal Ulcer 1.8%
Drug Eruption 1.6%
Back Pain 1.3%
Pneumocystis Jiroveci Pneumonia 9.5%
Interstitial Lung Disease 8.7%
Pneumonia 8.7%
Vomiting 7.9%
White Blood Cell Count Decreased 7.9%
Staphylococcal Sepsis 5.6%
Ventricular Tachycardia 5.6%
Spinal Compression Fracture 4.8%
Pyrexia 4.0%
Tuberculosis 4.0%
Urticaria 4.0%
White Blood Cell Count Increased 4.0%
Anaemia 3.2%
Loss Of Consciousness 3.2%
Muscular Weakness 3.2%
Ovarian Epithelial Cancer 3.2%
Pneumothorax 3.2%
Rash 3.2%
Renal Disorder 3.2%
Temporal Lobe Epilepsy 3.2%

Drug Data